Christopher Moertel

12PUBLICATIONS
136CO-AUTHORS
Neurology and neuromuscular diseasesCentral nervous systemHaematological tumoursMolecular targetsPaediatrics not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 02, 2025
Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.

Kyle B Williams, Alex T Larsson, Bryant J Keller

|Mar 19, 2025
Reply to: Challenges in Assessing Response in Clinical Trials for Neurofibromatosis Type 1 Plexiform Neurofibromas.

Christopher L Moertel, Angela C Hirbe, Laura J Klesse

|Dec 03, 2024
Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions.

Audrey-Anne Lamoureux, Michael J Fisher, Lauriane Lemelle

|Nov 08, 2024
ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma.

Christopher L Moertel, Angela C Hirbe, Hans H Shuhaiber

|Apr 27, 2024
The OTX2 Gene Induces Tumor Growth and Triggers Leptomeningeal Metastasis by Regulating the mTORC2 Signaling Pathway in Group 3 Medulloblastomas.

Elisabet Ampudia-Mesias, Charles S Cameron, Eunjae Yoo

|Apr 08, 2024
Pharmacogenomic synthetic lethal screens reveal hidden vulnerabilities and new therapeutic approaches for treatment of NF1-associated tumors.

Kyle B Williams, Alex T Larsson, Bryant J Keller

Pageof 2

Frequent Collaborators

2 joint publications

Minu M Bhunia

2 joint publications

Andrea T Franson

2 joint publications

Nancy Ratner

2 joint publications

Garrett M Draper